Drucil Injection

5-Fluorouracil (5-FU)

250mg/10ml

Healthcare Pharmaceuticals Ltd.

Pack size
Unite Price	100.00 BDT

Indications

Drucil Injection is used for: Palliation of malignant neoplasms, Superficial basal cell carcinoma, Oesophageal carcinoma, Carcinoma of Colon, Carcinoma of Breast, Carcinoma of Ovary, Carcinoma of Liver, Carcinoma of Pancreas, Carcinoma of Rectum, Carcinoma of Stomach

Adult Dose

Adult: IV Palliation of malignant neoplasms 12 mg/kg/day (max: 0.8-1g/day) for 3-4 days, if no toxicity occurs, may be followed after 1 day w/ 6 mg/kg on alternate days for another 3-4 doses. May repeat course 4-6 wk later or maintenance doses of 5-15 mg/kg (max: 1 g) may be given wkly. Cancers of Colon, Breast, Ovary, Liver, Pancreas, Rectum, Stomach Various protocols exist 500 mg/sq.meter IV on Days 1-5, OR 450-600 mg/sq.meter IV weekly, OR 200-400 mg/sq.meter IV continuous infusion qD Not to exceed 800 mg/day As an infusion: 15 mg/kg/day (max: 1 g/day), continue until toxicity occurs or a total of 12-15 g is given. May repeat course 4-6 wk later. Intra-arterial Palliation of malignant neoplasms 5-7.5 mg/kg/day as continuous infusion (regional perfusion). Hepatic impairment: Dose reduction may be required.

Child Dose

Child: Safety & efficacy not established.

Renal Dose

Renal impairment: Dose reduction may be required.

Administration

IV Preparation IV Push: dose/syringe (concentration: 50 mg/mL); max syringe size for IVP is 30 mL syringe and syringe should be <75% full Continuous IV Infusion/IVPB: dose/50-1000 mL D5W or NS; syringe and solution are stable for 72 hr at 4 to 25°C IV Administration Direct IV push injection (50 mg/mL solution needs no further dilution) or by IV infusion Toxicity may be reduced by giving the drug as a constant infusion Bolus doses may be administered by slow IVP or IVPB Warm to body temperature before using Continuous IV infusion may be administered in D5W or NS Solution should be protected from direct sunlight 5-FU may also be administered intra-arterially or intra-hepatically Use plastic IV containers for continuous infusions (stable in plastic IV bags than in glass bottles)

Contra Indications

Topical application on mucous membranes, exposure to sunlight, hypersensitivity. Depressed bone marrow function, poor nutritional status, potentially serious infections. Pregnancy and lactation.

Precautions

Regular monitoring of blood counts. History of heart disease, hepatic or renal insufficiency, weak or malnourished patients, patients who with history of high-dose pelvic radiation or use of alkylating agents. Patients with widespread metastases to the bone marrow. Lactation: excretion in milk unknown; do not nurse.

Pregnancy-Lactation

Pregnancy Category: D Risk Summary There are no adequate and well-controlled studies with fluorouracil in pregnant women. Based on its mechanism of action, fluorouracil can cause fetal harm when administered to a pregnant woman. Lactation: excretion in milk unknown; do not nurse

Interactions

May increase warfarin effects. May reduce response to vaccines; possibility of generalized infection with live vaccines. Action may be modified by allopurinol. Leucovorin calcium may enhance the toxicity of fluorouracil.

Side Effects

Side effects of 5-Fluorouracil (5-FU) : 1-10% Loss of appetite, Headache, Nausea, Vomiting, Diarrhea, Mucositis, Myelosuppression, Alopecia, Photosensitivity, Hand-foot syndrome, Maculopapular eruption (pruritic) Frequency Not Defined Angina, Coronary arteriosclerosis, Thrombophlebitis, Darkening of veins, Gastrointestinal ulcer, Increased alkaline phosphatase, Increased LFTs, Hyperbilirubinemia, Hypercholesterolemia (increased LDH), Anaphylaxis, Nystagmus, Ophthalmic findings Potentially Fatal: Central neurotoxicity, myocardial ischaemia.

Mode of Action

Fluorouracil interferes with DNA synthesis by blocking the conversion of deoxyuridylic acid to thymidylic acid. It also interferes with RNA synthesis. This results in an unbalanced growth of the cells. Fluorouracil exerts greater effect on rapidly growing cells as they take up the drug at a faster rate.

Note

Drucil 250mg/10ml Injection generic name is 5-Fluorouracil (5-FU). Drucil 250mg/10ml Injection is manufactured by Healthcare Pharmaceuticals Ltd.Drucil is availble in all over Bangladesh. Mes BD drug index information on Drucil Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of 5-Fluorouracil (5-FU) :

Injection

Fluroxan ^250mg/10ml

Beacon Pharmaceuticals Ltd.

Injection

Fluroxan ^500mg/10ml

Beacon Pharmaceuticals Ltd.

Injection

5-Fu ^250mg/10ml

Choongwae Pharma Corporation,Korea

Injection

5-Fu ^250mg/10ml

Choongwae Pharma Corporation,Korea

Injection

Fluracedyl ^500mg/10ml

Pharmachemie B. V. Netherlands